Specifications

127
will seek full recognition if the benefit of incorporating will exceed our process
cost.
6.1.3 Targeted Consumer
Our main targeted consumer group is between the age of 18-25, simply because
by study, this is age group is the top contributor to the drunk driving fatality rate
every year, however this does not exclude a focus on individuals older than 25,
as there are many repeat DUI offenders within this age category as well. Our
product is designed to be appealing to this younger crowds, a more stylish,
minimalistic design that will fit in a college student’s Mustang or G35 without
taking away their passion for their car’s interior look, while also allowing
portability and convenience of use.
6.1.4 Governmental Approvals and Recognitions
Upon the completion of our final design and testing, our product maybe be
applied to receive FDA –CDRH approval. The U.S. Food and Drug
Administration's Center for Devices and Radiological Health (CDRH) is
responsible for regulating firms who manufacture, repackage, re-label, and/or
import medical devices sold in the United States. We will follow FDA’s guideline
and allow their science experts to review our data in order to be granted an
approval to sell the product.
In addition to FDA approval, we will apply to be able to label our product as a
DOT / NHTSA approved as an alcohol screening device in order to be
competitive among other designs and to have an upper edge in competing for
governmental contract.
6.2 Project Planning
6.2.1 Fall 2009 Semester
The following milestones and objectives are set to ensure Voog breathalyzers
are completed on a designated date, which will be the end of Spring 2010
semesters. Although, some procedures might not be occurring in the exact
sequence as listed below, this guideline will continue to be use and follow to its
full extend. Our goal for fall semester is to have a complete documentation of our
finalized project idea. Although future modification and adjustment are expected,
it is our goal to have evaluated all circumstances. This is summarized in Table
6.2.1.